Citation Impact
Citing Papers
Vaginal microbiome of reproductive-age women
2010 Standout
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection
2004
Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection
2007 StandoutNobel
gp340 Expressed on Human Genital Epithelia Binds HIV-1 Envelope Protein and Facilitates Viral Transmission
2007 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Inhibiting sexual transmission of HIV-1 infection
2003
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Toward an HIV Type 1 Vaccine that Generates Potent, Broadly Cross-Reactive Neutralizing Antibodies
1999
HIV preferentially infects HIV-specific CD4+ T cells
2002 Nature
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
2007 StandoutNobel
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
2005
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor
2010 StandoutNatureNobel
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Antibody neutralization and escape by HIV-1
2003 StandoutNature
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
2002 Standout
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
2008
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
Neutralizing antiviral antibody responses
2001
Interclade Neutralization and Enhancement of Human Immunodeficiency Virus Type 1 Identified by an Assay Using HeLa Cells Expressing Both CD4 Receptor and CXCR4/CCR5 Coreceptors
2004 StandoutNobel
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Structured Treatment Interruptions for the Management of HIV Infection
2001
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
A Luciferase-Reporter Gene-Expressing T-Cell Line Facilitates Neutralization and Drug-Sensitivity Assays That Use Either R5 or X4 Strains of Human Immunodeficiency Virus Type 1
2001
Vaccines against intracellular infections requiring cellular immunity
2000 Nature
HIV Drug Resistance
2004
Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
2008 StandoutNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
2006 Standout
Proline-catalysed Mannich reactions of acetaldehyde
2008 StandoutNatureNobel
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
2011 StandoutNatureNobel
Immunological recovery and antiretroviral therapy in HIV-1 infection
2006
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
2005 StandoutNature
A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses
2011
Exploitation of Cellular Signaling by HIV-1: Unwelcome Guests with Master Keys That Signal Their Entry
2000
Cancer-related inflammation
2008 StandoutNature
Mechanisms of gene silencing by double-stranded RNA
2004 StandoutNature
Equivalent Immunogenicity of the Highly Attenuated Poxvirus-Based ALVAC-SIV and NYVAC-SIV Vaccine Candidates in SIVmac251-Infected Macaques
2002
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
1999
HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors
2003
Replication of hepatitis C virus
2007 StandoutNobel
Propagation and Dissemination of Infection after Vaginal Transmission of Simian Immunodeficiency Virus
2005
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Nucleic Acid-Based Immune System: the Antiviral Potential of Mammalian RNA Silencing
2003
Simian Immunodeficiency Virus SIVagm.sab Infection of Caribbean African Green Monkeys: a New Model for the Study of SIV Pathogenesis in Natural Hosts
2006 StandoutNobel
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
HIV Envelope Binding by Macrophage-Expressed gp340 Promotes HIV-1 Infection
2008 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract
2004
Envelope-Dependent, Cyclophilin-Independent Effects of Glycosaminoglycans on Human Immunodeficiency Virus Type 1 Attachment and Infection
2002
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity
2005
Unmutated Immunoglobulin M Can Protect Mice from Death by Influenza Virus Infection
2003 StandoutNobel
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
HIV Transmission
2004
The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus Infection
2008
Multiple nonfunctional alleles of CCR5 are frequent in various human populations
2000
Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection
2001
HIV-1 entry inhibitors: Evading the issue
1999
Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus
2009
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Multiple nonfunctional alleles of CCR5 are frequent in various human populations
2000
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans
2005
Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes
1999
Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists
2006
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
2000
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
HIV VACCINES
2005
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Determinants of CD4 Independence for a Human Immunodeficiency Virus Type 1 Variant Map outside Regions Required for Coreceptor Specificity
1999
REGULATION OF PROTEIN FUNCTION BY GLYCOSAMINOGLYCANS—AS EXEMPLIFIED BY CHEMOKINES
2003
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes.
2008 Nobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells
2001 StandoutNobel
Highly pathogenic SHIVs and SIVs target different CD4+T cell subsets in rhesus monkeys, explaining their divergent clinical courses
2004
Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors
2004
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation
2001 StandoutNobel
Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue
2004
RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
2011 StandoutNobel
Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection
2004
Works of Tom Ketas being referenced
HIV Type 1 Molecular Clones Able to Use the Bonzo/STRL-33 Coreceptor for Virus Entry
2001
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
2003
HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
1999
The Effect of Highly Active Antiretroviral Therapy on Binding and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Infection
2000
A Cell Line-Based Neutralization Assay for Primary Human Immunodeficiency Virus Type 1 Isolates That Use either the CCR5 or the CXCR4 Coreceptor
1999
Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry
2003
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
2002
The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That Enhances Viral Infectivity
1999
Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage
1998